Table 1

 Descriptive characteristics of the study population according to sex, Zwyat Razin, 2003

Males (n = 309)Females (n = 456)
BMI, body mass index; DBP, diastolic blood pressure; HCV, hepatitis C virus; HDL, high density lipoprotein; LDL, low density lipoprotein; SBP, systolic blood pressure; WHR, waist hip ratio.
Descriptive characteristics (n (%))
    Age group (y)
        25–3493 (30.1)131 (28.7)
        35–4483 (26.9)138 (30.3)
        45–5461 (19.7)95 (20.8)
        55–6434 (11.0)60 (13.2)
        ⩾6538 (12.3)32 (7.0)
    HCV infection status
        Never infected224 (72.5)361 (79.2)
        Past infection22 (7.1)45 (9.9)
        Chronic infection63 (20.4)50 (11.0)
Clinical examination (mean (SD))
    Height (cm)167.9 (7.0)155.1 (6.4)
    Weight (kg)72.5 (13.8)69.7 (15.9)
    BMI (kg/m2)25.7 (4.5)28.9 (6.3)
    Waist circumference (cm)86.5 (12.3)90.3 (14.6)
    WHR0.90 (0.08)0.88 (0.08)
    SBP (mm Hg)124.6 (19.8)124.6 (22.5)
    DBP (mm Hg)80.7 (10.7)80.6 (12.3)
Metabolic variables (mean (SD))
    Fasting glucose (mg/dl)85.5 (22.5)88.3 (33.0)
    Total cholesterol (mg/dl)171.6 (37.8)183.8 (41.0)
    LDL cholesterol (mg/dl)104.2 (34.7)110.4 (37.4)
    HDL cholesterol (mg/dl)42.8 (9.0)50.0 (11.6)
    Triglycerides (mg/dl)123.4 (62.6)117.5 (64.9)
Current treatments (n (%))
    Antihypertensive drugs24 (7.8)52 (11.4)
    Oral antidiabetic drugs8 (2.6)16 (3.5)
    Insulin3 (1.0)3 (0.7)
    Cholesterol lowering drugs1 (0.3)3 (0.7)